/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

E

Emily Austin

Hospital for Sick Children(CA)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

62

Papers

2.6K

Citations

15

h-index

17

i10-index

Emily Austin is an academic researcher from Hospital for Sick Children. The author has contributed to research in topics: Poisoning and overdose treatments & COVID-19 Clinical Research Studies & SARS-CoV-2 and COVID-19 Research. The author has an h-index of 15, co-authored 53 publications.

ORCID: 0000-0002-8967-9691

Research Topics

Poisoning and overdose treatments COVID-19 Clinical Research Studies SARS-CoV-2 and COVID-19 Research Long-Term Effects of COVID-19 Anesthesia and Sedative Agents

Papers by this author

works

Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

2021 · The Lancet · 556 citations

https://doi.org/10.1016/s0140-6736(21)00149-5

Eugenia Abaleke Mustafa Abbas Sadia Abbasi Alfie Abbott

Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial

2021 · The Lancet · 516 citations

https://doi.org/10.1016/s0140-6736(21)00897-7

Obbina Abani Ali Abbas Fatima Abbas Mustafa Abbas

Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis

2022 · The Lancet · 320 citations

https://doi.org/10.1016/s0140-6736(22)01109-6

Obbina Abani Ali Abbas Fatima Abbas Joshua Abbas

Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

2021 · The Lancet · 289 citations

https://doi.org/10.1016/s0140-6736(21)01825-0

Obbina Abani Ali Abbas Fatima Abbas Mustafa Abbas

Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

2023 · The Lancet Diabetes & Endocrinology · 36 citations

https://doi.org/10.1016/s2213-8587(23)00253-x

Obbina Abani Amr E. Abbas Fatima Abbas Jonathan R. Abbas

Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial

2024 · The Lancet Child & Adolescent Health · 33 citations

https://doi.org/10.1016/s2352-4642(23)00316-4

Saul N. Faust Richard Haynes Christine E. Jones Natalie Staplin

Research topics

topics

Poisoning and overdose treatments

COVID-19 Clinical Research Studies

SARS-CoV-2 and COVID-19 Research

Long-Term Effects of COVID-19

Anesthesia and Sedative Agents

Chat about Author

Papers

Chat

Click to start Chat